Diplegic Spastic Cerebral PalsyNCT06913114
Relationship Between Hip Extensor Strength and Gait Speed in Diplegic Cerebral Palsy
An observational study of Diplegic Spastic Cerebral Palsy, run by Cairo University at 1 site in Egypt.
Trial summary
The hip extensors are essential for upright posture and forward propulsion during gait. Children with diplegic CP often demonstrate reduced muscle strength, which impacts their gait speed and overall mobility. Read more about this study
- Who is it for?
- Ages 6 to 8 years
- Conditions the study is for
- Diplegic Spastic Cerebral Palsy
- What is being tested?
- Lafayette
- How many people
- 20 participants
- Where
- 1 siteEgypt
- Study dates
- 15 Jan 2025to 15 Aug 2025
- Phase
- Observational
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 8 years
- All sexes
- No healthy volunteers
- Child
Study population: Children with diplegic CP who can walk
Who may be able to join
- • Diagnosed with diplegic CP
- Ages 6 - 8 years
- GMFCS Levels I-II (indicating they are ambulatory)
- Able to follow instructions and participate in strength and gait assessments
Who cannot join
- • Severe cognitive or behavioral impairments affecting participation
- Musculoskeletal conditions or recent orthopedic surgery that could interfere with hip function
- Use of assistive devices for ambulation
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Exploring the Relationship Between Hip Extensor Strength and Gait Speed in Diplegic Cerebral Palsy: A Feasibility Pilot Study
The hip extensors are essential for upright posture and forward propulsion during gait. Children with diplegic CP often demonstrate reduced muscle strength, which impacts their gait speed and overall mobility. Understanding the relationship between hip extensor strength and gait speed could provide a basis for targeted interventions. This feasibility study will establish whether the handheld dynamometer can reliably measure hip extensor strength and if this strength correlates with gait speed in children with diplegic CP.
- Conditions
- Diplegic Spastic Cerebral Palsy
- Being tested
- Lafayette
- Medical subject headings
- Cerebral palsy, spastic, diplegic
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
LafayetteDiagnostic test
The Lafayette handheld dynamometer data correlates with the measurements taken using the 10-Meter Walk Test (10MWT) or not.
LafayetteDiagnostic test
Lafayette handheld dynamometer.
| Study group | Role | What they receive |
|---|---|---|
| study group | Not described Receives: Diagnostic Test: Lafayette |
What is being measured
The primary outcome is the main question the study is designed to answer.
Hip Extensor Strength
Hip extensor strength measured using a Lafayette handheld dynamometer.
Measured: 4 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Apr 2025
- Study start15 Jan 2025
- Primary completion1 May 2025 (estimated)
- Study completion15 Aug 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Diplegic Spastic Cerebral PalsyStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 20 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Esraa Abd Elaziz Anter, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06913114
- Sponsor's protocol ID
- P.T.REC/012/005620
- Status last verified
- Apr 2025
- First submitted
- 29 Mar 2025
- Last updated
- 9 Apr 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No